Reckon Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 14-12-2024
- Paid Up Capital ₹ 10.00 Cr
as on 14-12-2024
- Company Age 23 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 18.85 Cr
as on 14-12-2024
- Revenue %
(FY 2022)
- Profit 665.93%
(FY 2022)
- Ebitda -0.43%
(FY 2022)
- Net Worth 3.97%
(FY 2022)
- Total Assets -0.67%
(FY 2022)
About Reckon Pharmachem
The Corporate was formerly known as Nb Welcome Chemicals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 10.00 Cr.
The company has closed loans amounting to ₹18.85 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Reckon Pharmachem Private Limited India is Happy Jaju as COMPANY SECRETARY. Vimal Aggarwal and Mohanan Karunakaran serve as directors at the Company.
- CIN/LLPIN
U24231DL2001PTC186327
- Company No.
186327
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2001
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Reckon Pharmachem Private Limited offer?
Reckon Pharmachem Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Vitamin Powder API.
Who are the key members and board of directors at Reckon Pharmachem?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Happy Jaju | Company Secretary | 10-Dec-2024 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohanan Karunakaran  | Additional Director | 15-Dec-2018 | Current |
| Vimal Aggarwal | Director | 01-Jul-2016 | Current |
Financial Performance and Corporate Structure Insights of Reckon Pharmachem.
Reckon Pharmachem Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 665.93% increase in profit. The company's net worth moved up by a moderate rise of 3.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Reckon Pharmachem?
In 2022, Reckon Pharmachem had a promoter holding of 94.45% and a public holding of 5.55%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 23 Jul 2004 | ₹18.85 Cr | Satisfied |
How Many Employees Work at Reckon Pharmachem?
Reckon Pharmachem has a workforce of 0 employees as of Mar 21, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Reckon Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Reckon Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
